Actively Recruiting
Study of VERAFEYE Anatomical Guidance System in Adults Undergoing Catheter Ablation for Atrial Flutter and Atrial Fibrillation
Led by LUMA Vision Ltd. · Updated on 2026-07-07
50
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the use of the VERAFEYE Anatomical Guidance System in adults undergoing catheter ablation for treating Atrial Flutter AFL, paroxysmal Atrial Fibrillation PAF, or persistent Atrial Fibrillation perAF. The study aims to collect data on how this device is used during these procedures, focusing on acute procedural success and overall management of AFLAF ablation treatments. The findings may help improve the VERAFEYE system for future use. The VERAFEYE Anatomical Guidance System will be used during standard catheter-based ablation treatments for AFL and AF. This device is applied as part of routine care while performing the catheter ablation procedure. Participants will undergo the treatment following current international and local guidelines as determined by their physician. Participants will be involved in the study during their catheter ablation procedure where data on procedural success will be collected. Screening for left atrial thrombus is required before or during the procedure to ensure safety. Researchers will monitor acute procedural success rates during the index procedure. The total study duration extends through the completion of the procedure and associated assessments.
CONDITIONS
Brief Title
Anatomical Navigation for Guided Electrophysiology in AFL and AFib
Research Team
A
Alisa Komleva
E
Elke Sommerijns
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
